|
GB201810849D0
|
|
Intermediates in the synthesis of C3-substituted cephalosporins
|
|
GB201613842D0
|
|
Moxidectin topical liquid formulations
|
|
GB201418783D0
|
|
Anthelminthic macrolide synthesis
|
|
GB201418363D0
|
|
Proton Pump Inhibitor Paste Compositions
|
|
GB201411310D0
|
|
Stable methimazole liquid compositions
|
|
GB201403980D0
|
|
Novel Isoxazolines and their uses
|
|
GB201400988D0
|
|
Herbal composition and its use for modifying animal behavior
|
|
GB201319762D0
|
|
Tulathromycin and nonsteroidal anti-inflammatory drug compositions
|
|
WO2015055974A1
|
|
Proton pump inhibitor paste compositions
|
|
NZ702107A
|
|
Avermectin pour-on formulation with reduced withdrawal time
|
|
GB201215349D0
|
|
Avermectin pour-on formulation with reduced withdrawal time
|
|
GB201207767D0
|
|
Avermectin pour-on formulation with reduced withdrawal time
|
|
GB201117858D0
|
|
Paste
|
|
GB201113606D0
|
|
Dual chamber syringe
|
|
AU2011203581A1
|
|
Anthelmintic composition
|
|
GB201105633D0
|
|
Antibotic compounds
|
|
GB201021836D0
|
|
Topical Composition
|
|
TN2010000422A1
|
|
A topical ectoparasiticide composition
|
|
HK1125645A1
|
|
Chemical process for the preparation of medetomidine
|
|
GB0906861D0
|
|
Teat seal composition
|
